Impact of maternal age on obstetric and neonatal morbidity: a retrospective cohort study.
Advanced maternal age pregnancies
Age
Neonatal morbidity
Obstetric morbidity
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
28 Oct 2021
28 Oct 2021
Historique:
received:
08
04
2021
accepted:
01
10
2021
entrez:
29
10
2021
pubmed:
30
10
2021
medline:
21
12
2021
Statut:
epublish
Résumé
Pregnancies in women over 35 years of age are becoming more frequent. The majority of studies point to an age of 35 as a provider of obstetric and neonatal complications. But several confounding factors are not taken into account and this results in contradictory results. The objective was to quantify the strength of the association between maternal age and obstetric and neonatal morbidity. This observational study was based on systematic records of 9 years of pregnancies managed in the Obstetrics and Gynaecology Department of Antoine Béclère Hospital, Clamart, France. In all, 24,674 pregnancies were managed at Antoine Béclère Hospital between April 1, 2007 and December 31, 2015, including 23,291 singleton pregnancies. Maternal age was the age at the beginning of pregnancy, taken as a quantitative variable. The main outcome measure was a composite "unfavourable" pregnancy outcome that included miscarriage, induced abortion, in utero foetal death, stillborn or newborn infant weighing under 500 g or delivered before 24 weeks of gestational age. Obstetric and neonatal morbidity comprised hospitalisation during pregnancy for more than 1 day, pre-eclampsia, gestational diabetes requiring hospitalisation, caesarean delivery, preterm birth, small-for-gestational age, and newborn transfer to the paediatric unit or neonatal intensive care unit. Analyses were conducted among singleton pregnancies (n = 23,291) and were adjusted for obesity, assisted reproductive technology and geographical origin of the mother. Unfavourable pregnancy outcome rate tripled with age, from 5% among women aged 25 to 34 to 16% among those over 45. Women over 40 were twice as likely to be hospitalised as those aged 25 to 34. The caesarean section rate reached more than 40% among women over 40 and more than 60% in women over 45. The rate of newborn transfer to paediatric intensive care or a neonatal intensive care unit was doubled in women over 40 and small-for-gestational age was more frequent with age, reaching 34% in women over 45. The risk of maternal-foetal complications increases steadily with age and is particularly high after 35 years and closer monitoring appears to be necessary. These results provide additional evidence and information for public health decision-makers.
Sections du résumé
BACKGROUND
BACKGROUND
Pregnancies in women over 35 years of age are becoming more frequent. The majority of studies point to an age of 35 as a provider of obstetric and neonatal complications. But several confounding factors are not taken into account and this results in contradictory results.
METHODS
METHODS
The objective was to quantify the strength of the association between maternal age and obstetric and neonatal morbidity. This observational study was based on systematic records of 9 years of pregnancies managed in the Obstetrics and Gynaecology Department of Antoine Béclère Hospital, Clamart, France. In all, 24,674 pregnancies were managed at Antoine Béclère Hospital between April 1, 2007 and December 31, 2015, including 23,291 singleton pregnancies. Maternal age was the age at the beginning of pregnancy, taken as a quantitative variable. The main outcome measure was a composite "unfavourable" pregnancy outcome that included miscarriage, induced abortion, in utero foetal death, stillborn or newborn infant weighing under 500 g or delivered before 24 weeks of gestational age. Obstetric and neonatal morbidity comprised hospitalisation during pregnancy for more than 1 day, pre-eclampsia, gestational diabetes requiring hospitalisation, caesarean delivery, preterm birth, small-for-gestational age, and newborn transfer to the paediatric unit or neonatal intensive care unit.
RESULTS
RESULTS
Analyses were conducted among singleton pregnancies (n = 23,291) and were adjusted for obesity, assisted reproductive technology and geographical origin of the mother. Unfavourable pregnancy outcome rate tripled with age, from 5% among women aged 25 to 34 to 16% among those over 45. Women over 40 were twice as likely to be hospitalised as those aged 25 to 34. The caesarean section rate reached more than 40% among women over 40 and more than 60% in women over 45. The rate of newborn transfer to paediatric intensive care or a neonatal intensive care unit was doubled in women over 40 and small-for-gestational age was more frequent with age, reaching 34% in women over 45.
CONCLUSIONS
CONCLUSIONS
The risk of maternal-foetal complications increases steadily with age and is particularly high after 35 years and closer monitoring appears to be necessary. These results provide additional evidence and information for public health decision-makers.
Identifiants
pubmed: 34711168
doi: 10.1186/s12884-021-04177-7
pii: 10.1186/s12884-021-04177-7
pmc: PMC8555100
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
732Informations de copyright
© 2021. The Author(s).
Références
J Reprod Med. 2007 Jul;52(7):585-90
pubmed: 17847755
PLoS One. 2014 Apr 25;9(4):e96237
pubmed: 24769856
Fertil Steril. 2017 Apr;107(4):948-953.e1
pubmed: 28283263
Obstet Gynecol. 2018 Mar;131(3):457-463
pubmed: 29420406
Obstet Gynecol. 1999 Jan;93(1):9-14
pubmed: 9916947
J Obstet Gynaecol Res. 2000 Feb;26(1):27-30
pubmed: 10761327
J Gynecol Obstet Hum Reprod. 2017 Dec;46(10):701-713
pubmed: 29031048
Hum Reprod. 2007 May;22(5):1264-72
pubmed: 17289684
Hum Reprod. 2019 Oct 2;34(10):1906-1914
pubmed: 31560763
J Gynecol Obstet Biol Reprod (Paris). 2007 Feb;36(1):50-6
pubmed: 17254718
Epidemiology. 2018 May;29(3):379-387
pubmed: 29517506
Am J Obstet Gynecol. 2010 Dec;203(6):558.e1-7
pubmed: 20965486
Am J Public Health. 2020 Sep;110(9):1418-1420
pubmed: 32673116
N Engl J Med. 1990 Mar 8;322(10):659-64
pubmed: 2304491
J Matern Fetal Neonatal Med. 2019 May;32(10):1602-1608
pubmed: 29216770
J Gynecol Obstet Biol Reprod (Paris). 2012 Sep;41(5):468-75
pubmed: 22622192
J Matern Fetal Neonatal Med. 2009 Jul;22(7):593-6
pubmed: 19488951
Obstet Gynecol. 2004 Oct;104(4):727-33
pubmed: 15458893
J Matern Fetal Neonatal Med. 2012 Nov;25(11):2190-3
pubmed: 22524796
Obstet Gynecol. 1998 Dec;92(6):935-9
pubmed: 9840553
Eur J Obstet Gynecol Reprod Biol. 2007 Nov;135(1):41-6
pubmed: 17118520
J Obstet Gynaecol Can. 2018 Sep;40(9):1208-1218
pubmed: 29681506
JAMA Netw Open. 2019 Aug 2;2(8):e199875
pubmed: 31441937
Obstet Gynecol. 2005 Jun;105(6):1410-8
pubmed: 15932837
Am J Obstet Gynecol. 2007 May;196(5):e11-3
pubmed: 17466664
J Matern Fetal Neonatal Med. 2015 Jan;28(1):59-62
pubmed: 24593845
Obstet Gynecol. 1996 Jun;87(6):917-22
pubmed: 8649698
BMJ. 2005 Sep 17;331(7517):588-9
pubmed: 16166111